BRM
MRK icon

Boston Research & Management’s Merck MRK Stock Holding History

Boston Research & Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.01M Buy
66,572
+578
+0.9% +$66.7K 1.9% 14
2025
Q4 		$6.95M Sell
65,994
-1,621
-2% -$152K 1.6% 21
2025
Q3 		$5.67M Buy
67,615
+256
+0.4% +$21.1K 1.25% 31
2025
Q2 		$5.33M Buy
67,359
+4,473
+7% +$356K 1.27% 35
2025
Q1 		$5.64M Sell
62,886
-1,190
-2% -$111K 1.4% 28
2024
Q4 		$6.37M Buy
64,076
+1,746
+3% +$180K 1.56% 24
2024
Q3 		$7.08M Buy
62,330
+1,566
+3% +$186K 1.66% 21
2024
Q2 		$7.52M Sell
60,764
-761
-1% -$98K 1.9% 12
2024
Q1 		$8.12M Hold
61,525
– – 2.01% 11
2023
Q4 		$6.71M Buy
61,525
+1,415
+2% +$147K 1.78% 18
2023
Q3 		$6.19M Sell
60,110
-272
-0.5% -$29.3K 1.83% 16
2023
Q2 		$6.97M Sell
60,382
-1
-0% -$114 1.97% 14
2023
Q1 		$6.42M Sell
60,383
-911
-1% -$98.4K 1.92% 14
2022
Q4 		$6.8M Sell
61,294
-1,220
-2% -$125K 2.1% 11
2022
Q3 		$5.38M Buy
62,514
+120
+0.2% +$10.7K 1.83% 16
2022
Q2 		$5.69M Sell
62,394
-170
-0.3% -$15.1K 1.84% 15
2022
Q1 		$5.13M Sell
62,564
-510
-0.8% -$40.2K 1.49% 24
2021
Q4 		$4.83M Buy
63,074
+105
+0.2% +$8.36K 1.32% 29
2021
Q3 		$4.73M Buy
62,969
+3,015
+5% +$229K 1.41% 30
2021
Q2 		$4.66M Buy
59,954
+633
+1% +$47.1K 1.41% 31
2021
Q1 		$4.36M Buy
59,321
+5,460
+10% +$403K 1.4% 33
2020
Q4 		$4.2M Buy
53,861
+2,846
+6% +$218K 1.46% 33
2020
Q3 		$4.04M Sell
51,015
-1,200
-2% -$94K 1.58% 30
2020
Q2 		$3.85M Buy
52,215
+1,355
+3% +$102K 1.6% 27
2020
Q1 		$3.73M Buy
50,860
+201
+0.4% +$15.8K 1.87% 24
2019
Q4 		$4.4M Sell
50,659
-6
-0% -$493 1.65% 28
2019
Q3 		$4.07M Buy
50,665
+860
+2% +$68.9K 1.61% 32
2019
Q2 		$3.98M Buy
49,805
+922
+2% +$70.6K 1.61% 30
2019
Q1 		$3.88M Sell
48,883
-1,263
-3% -$94.5K 1.62% 31
2018
Q4 		$3.66M Buy
50,146
+4,737
+10% +$334K 1.74% 25
2018
Q3 		$3.07M Buy
45,409
+147
+0.3% +$9.37K 1.4% 35
2018
Q2 		$2.62M Buy
45,262
+672
+2% +$37.9K 1.29% 42
2018
Q1 		$2.32M Buy
44,590
+39,253
+735% +$2.12M 1.18% 43
2017
Q4 		$286K Sell
5,337
-2,442
-31% -$135K 0.14% 86
2017
Q3 		$475K Buy
7,779
+188
+2% +$11.4K 0.24% 71
2017
Q2 		$464K Hold
7,591
– – 0.25% 72
2017
Q1 		$460K Hold
7,591
– – 0.25% 73
2016
Q4 		$426K Hold
7,591
– – 0.24% 76
2016
Q3 		$452K Hold
7,591
– – 0.26% 71
2016
Q2 		$417K Hold
7,591
– – 0.25% 75
2016
Q1 		$383K Hold
7,591
– – 0.24% 79
2015
Q4 		$382K Sell
7,591
-1,584
-17% -$79.9K 0.24% 80
2015
Q3 		$432K Buy
9,175
+1,048
+13% +$55.7K 0.28% 77
2015
Q2 		$441K Sell
8,127
-105
-1% -$5.89K 0.28% 75
2015
Q1 		$451K Hold
8,232
– – 0.29% 74
2014
Q4 		$446K Hold
8,232
– – 0.28% 76
2014
Q3 		$465K Hold
8,232
– – 0.31% 70
2014
Q2 		$454K Hold
8,232
– – 0.31% 68
2014
Q1 		$445K Buy
8,232
+537
+7% +$27.8K 0.33% 69
2013
Q4 		$367K Hold
7,695
– – 0.28% 69
2013
Q3 		$349K Hold
7,695
– – 0.29% 69
2013
Q2 		$341K Buy
+7,695
New +$344K 0.3% 70

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Research & Management's MRK Position: Q1 2026 in Review

Boston Research & Management increased its Merck (MRK) stake by 0.88% in Q1 2026, buying an estimated $66.7K and bringing the position to 66,572 shares worth $8.01M. The position accounts for 1.9% of the portfolio, ranked #14.

Boston Research & Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.12M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Boston Research & Management held 66,572 shares of Merck worth $8.01M as of Q1 2026.
  • Boston Research & Management bought 578 Merck shares in Q1 2026, an estimated $66.7K.
  • Merck made up 1.9% of Boston Research & Management's portfolio in Q1 2026, its #14 holding.
  • Boston Research & Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Boston Research & Management's Merck position peaked at $8.12M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.